Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms

Cardiovascular diseases are one of the leading causes of death worldwide and cardiac fibrosis is a common pathological process for cardiac remodeling in cardiovascular diseases. Cardiac fibrosis not only accelerates the deterioration progress of diseases but also becomes a pivotal contributor for fu...

Full description

Bibliographic Details
Main Authors: Xiao Li, Lin Li, Wei Lei, Hui Zi Chua, Zining Li, Xianglong Huang, Qilong Wang, Nan Li, Han Zhang
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221007617
id doaj-5c12caaf6ee64cfcb57de6a637180354
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Xiao Li
Lin Li
Wei Lei
Hui Zi Chua
Zining Li
Xianglong Huang
Qilong Wang
Nan Li
Han Zhang
spellingShingle Xiao Li
Lin Li
Wei Lei
Hui Zi Chua
Zining Li
Xianglong Huang
Qilong Wang
Nan Li
Han Zhang
Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
Biomedicine & Pharmacotherapy
Cardiac fibrosis
Traditional Chinese medicine
Bioactive compounds
Herbal extracts
Chinese herbal formulas
author_facet Xiao Li
Lin Li
Wei Lei
Hui Zi Chua
Zining Li
Xianglong Huang
Qilong Wang
Nan Li
Han Zhang
author_sort Xiao Li
title Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
title_short Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
title_full Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
title_fullStr Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
title_full_unstemmed Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
title_sort traditional chinese medicine as a therapeutic option for cardiac fibrosis: pharmacology and mechanisms
publisher Elsevier
series Biomedicine & Pharmacotherapy
issn 0753-3322
publishDate 2021-10-01
description Cardiovascular diseases are one of the leading causes of death worldwide and cardiac fibrosis is a common pathological process for cardiac remodeling in cardiovascular diseases. Cardiac fibrosis not only accelerates the deterioration progress of diseases but also becomes a pivotal contributor for futile treatment in clinical cardiovascular trials. Although cardiac fibrosis is common and prevalent, effective medicines to provide sufficient clinical intervention for cardiac fibrosis are still unavailable. Traditional Chinese medicine (TCM) is the natural essence experienced boiling, fry, and other processing methods, including active ingredients, extracts, and herbal formulas, which have been applied to treat human diseases for a long history. Recently, research has increasingly focused on the great potential of TCM for the prevention and treatment of cardiac fibrosis. Here, we aim to clarify the identified pro-fibrotic mechanisms and intensively summarize the application of TCM in improving cardiac fibrosis by working on these mechanisms. Through comprehensively analyzing, TCM mainly regulates the following pathways during ameliorating cardiac fibrosis: attenuation of inflammation and oxidative stress, inhibition of cardiac fibroblasts activation, reduction of extracellular matrix accumulation, modulation of the renin-angiotensin-aldosterone system, modulation of autophagy, regulation of metabolic-dependent mechanisms, and targeting microRNAs. We also discussed the deficiencies and the development direction of anti-fibrotic therapies on cardiac fibrosis. The data reviewed here demonstrates that TCM shows a robust effect on alleviating cardiac fibrosis, which provides us a rich source of new drugs or drug candidates. Besides, we also hope this review may give some enlightenment for treating cardiac fibrosis in clinical practice.
topic Cardiac fibrosis
Traditional Chinese medicine
Bioactive compounds
Herbal extracts
Chinese herbal formulas
url http://www.sciencedirect.com/science/article/pii/S0753332221007617
work_keys_str_mv AT xiaoli traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT linli traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT weilei traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT huizichua traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT ziningli traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT xianglonghuang traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT qilongwang traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT nanli traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
AT hanzhang traditionalchinesemedicineasatherapeuticoptionforcardiacfibrosispharmacologyandmechanisms
_version_ 1717376383914606592
spelling doaj-5c12caaf6ee64cfcb57de6a6371803542021-09-19T04:53:46ZengElsevierBiomedicine & Pharmacotherapy0753-33222021-10-01142111979Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanismsXiao Li0Lin Li1Wei Lei2Hui Zi Chua3Zining Li4Xianglong Huang5Qilong Wang6Nan Li7Han Zhang8State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, ChinaState Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, ChinaState Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, ChinaEvidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, ChinaState Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, ChinaFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, ChinaState Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, ChinaState Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, ChinaState Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Correspondence to: No. 10 Poyanghu Road., Jinghai District, Tianjin 301617, China.Cardiovascular diseases are one of the leading causes of death worldwide and cardiac fibrosis is a common pathological process for cardiac remodeling in cardiovascular diseases. Cardiac fibrosis not only accelerates the deterioration progress of diseases but also becomes a pivotal contributor for futile treatment in clinical cardiovascular trials. Although cardiac fibrosis is common and prevalent, effective medicines to provide sufficient clinical intervention for cardiac fibrosis are still unavailable. Traditional Chinese medicine (TCM) is the natural essence experienced boiling, fry, and other processing methods, including active ingredients, extracts, and herbal formulas, which have been applied to treat human diseases for a long history. Recently, research has increasingly focused on the great potential of TCM for the prevention and treatment of cardiac fibrosis. Here, we aim to clarify the identified pro-fibrotic mechanisms and intensively summarize the application of TCM in improving cardiac fibrosis by working on these mechanisms. Through comprehensively analyzing, TCM mainly regulates the following pathways during ameliorating cardiac fibrosis: attenuation of inflammation and oxidative stress, inhibition of cardiac fibroblasts activation, reduction of extracellular matrix accumulation, modulation of the renin-angiotensin-aldosterone system, modulation of autophagy, regulation of metabolic-dependent mechanisms, and targeting microRNAs. We also discussed the deficiencies and the development direction of anti-fibrotic therapies on cardiac fibrosis. The data reviewed here demonstrates that TCM shows a robust effect on alleviating cardiac fibrosis, which provides us a rich source of new drugs or drug candidates. Besides, we also hope this review may give some enlightenment for treating cardiac fibrosis in clinical practice.http://www.sciencedirect.com/science/article/pii/S0753332221007617Cardiac fibrosisTraditional Chinese medicineBioactive compoundsHerbal extractsChinese herbal formulas